Literature DB >> 26662627

CD56-positive lymphocyte infiltration in relation to human papillomavirus association and prognostic significance in oropharyngeal squamous cell carcinoma.

Steffen Wagner1, Claus Wittekindt1, Miriam Reuschenbach2, Ben Hennig3, Mauran Thevarajah1, Nora Würdemann1, Elena-Sophie Prigge2, Magnus von Knebel Doeberitz2, Thomas Dreyer3, Stefan Gattenlöhner3, Jens Peter Klussmann1.   

Abstract

Human papillomavirus (HPV)-related squamous cell carcinoma of the oropharynx (OSCC) are clinical and biological distinct from their HPV-unrelated counterparts. Patients with HPV-related OSCC display improved prognosis and therefore we investigated possible immune cell infiltrations associated with this tumor phenotype. We retrospectively analyzed a randomly selected cohort of 140 OSCC for presence of immune cells and HPV by immunohistochemistry and PCR followed by bead-based hybridization (Luminex technology). HPV prevalence was 24.3% as determined by positive staining of p16INK4a and detection of high risk HPV-DNA. We found significantly higher numbers of CD56 positive (CD56+) cells in tumor and surrounding microenvironment in HPV-associated compared to HPV-negative OSCC (t-test: p = 0.004 and p = 0.002). For the entire cohort presence of CD56+ cells was associated with increased overall survival independent from HPV (Kaplan-Meier: p = 0.002; Cox regression: p = 0.042). Presence of CD56+ cells also correlated with a better outcome in HPV-negative and especially in HPV-negative OSCC with alcohol consumption ≤ 2 standard drinks per day (Kaplan-Meier: p = 0.05 and p = 0.003). Immunofluorescence localization of granular Granzyme B (GZMB) within CD56+ cells and coexpression of CD16 and CD56 suggests that detected CD56+ cells mainly represent cytotoxic Natural Killer (NK) cells. The fraction of potentially cytotoxic NK cells was significantly higher in HPV-associated compared to HPV-negative OSCC (Mann-Whitney-U-Test: p = 0.011). The elevated abundance and activity of cytotoxic NK cells in OSCC with HPV driven carcinogenesis might contribute to favorable outcome in HPV-related OSCC.
© 2015 UICC.

Entities:  

Keywords:  CD56; HPV; head and neck; natural killer cell; orpharyngeal squamous cell carcinoma

Mesh:

Substances:

Year:  2016        PMID: 26662627     DOI: 10.1002/ijc.29962

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  26 in total

Review 1.  [The innate immune system in oropharyngeal squamous cell carcinoma : Immune modulation by HPV].

Authors:  S Wagner; H Böckmann; S Gattenlöhner; J P Klussmann; C Wittekindt
Journal:  HNO       Date:  2018-04       Impact factor: 1.284

2.  Immunometabolic Alterations by HPV Infection: New Dimensions to Head and Neck Cancer Disparity.

Authors:  Sanjib Chaudhary; Koelina Ganguly; Sakthivel Muniyan; Ramesh Pothuraju; Zafar Sayed; Dwight T Jones; Surinder K Batra; Muzafar A Macha
Journal:  J Natl Cancer Inst       Date:  2019-03-01       Impact factor: 13.506

Review 3.  [Tumor biology of oropharyngeal carcinoma].

Authors:  S Laban; M Brand; J Ezić; J Doescher; G Völkel; H A Kestler; C Brunner; T K Hoffmann
Journal:  HNO       Date:  2020-11-19       Impact factor: 1.284

4.  Treatment of Relapsing HPV Diseases by Restored Function of Natural Killer Cells.

Authors:  Andrea Lisco; Amy P Hsu; Dimana Dimitrova; Diana M Proctor; Emily M Mace; Peiying Ye; Megan V Anderson; Stephanie N Hicks; Christopher Grivas; Dima A Hammoud; Maura Manion; Gabriel J Starrett; Alvin Farrel; Kerry Dobbs; Isaac Brownell; Christopher Buck; Luigi D Notarangelo; Jordan S Orange; Warren J Leonard; Michael I Orestes; Anju T Peters; Jennifer A Kanakry; Julia A Segre; Heidi H Kong; Irini Sereti
Journal:  N Engl J Med       Date:  2021-09-02       Impact factor: 176.079

Review 5.  The 'Danse Macabre'-Neutrophils the Interactive Partner Affecting Oral Cancer Outcomes.

Authors:  Sara Hadjigol; Bansari A Shah; Neil M O'Brien-Simpson
Journal:  Front Immunol       Date:  2022-06-16       Impact factor: 8.786

Review 6.  Highlights from the Second International Symposium on HPV infection in head and neck cancer.

Authors:  Susanne Wiegand; G Wichmann; W Golusinski; C R Leemans; J P Klussmann; A Dietz
Journal:  Eur Arch Otorhinolaryngol       Date:  2018-03-27       Impact factor: 2.503

Review 7.  Tumor Immunity and Immunotherapy for HPV-Related Cancers.

Authors:  Achraf A Shamseddine; Bharat Burman; Nancy Y Lee; Dmitriy Zamarin; Nadeem Riaz
Journal:  Cancer Discov       Date:  2021-05-14       Impact factor: 39.397

8.  Immunotherapy Advances in Locally Advanced and Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma and Its Relationship With Human Papillomavirus.

Authors:  Huanhuan Wang; Qin Zhao; Yuyu Zhang; Qihe Zhang; Zhuangzhuang Zheng; Shiyu Liu; Zijing Liu; Lingbin Meng; Ying Xin; Xin Jiang
Journal:  Front Immunol       Date:  2021-07-08       Impact factor: 7.561

Review 9.  Immunotherapy for head and neck squamous cell carcinoma.

Authors:  Thorsten Fuereder
Journal:  Memo       Date:  2016-06-20

10.  Interleukin-15 enhances the proliferation, stimulatory phenotype, and antitumor effector functions of human gamma delta T cells.

Authors:  Heleen H Van Acker; Sébastien Anguille; Yannick Willemen; Johan M Van den Bergh; Zwi N Berneman; Eva Lion; Evelien L Smits; Viggo F Van Tendeloo
Journal:  J Hematol Oncol       Date:  2016-09-29       Impact factor: 17.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.